Heart Muscle Inflammation and Swelling Peak Twice After Heart Attack
New research findings by Mount Sinai Heart and CNIC in Spain challenges current medical consenus discovering heart attack causes two waves of heart muscle inflammation within a week.
Results of a new study challenge the current consensus in cardiology that peak myocardial edema, or heart muscle swelling, only occurs just after a myocardial infarction, or heart attack. In the study, presented as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific Sessions 2014 and published simultaneously in the Journal of the American College of Cardiology (JACC), scientists discovered a second wave of swelling and inflammation occurs within a week of a heart attack.
The researchers from the Mount Sinai Heart at Icahn School of Medicine at Mount Sinai and Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Spain believe their identification of this second wave of inflammation may advance the use of cardiac magnetic resonance (CMR) imaging to better assess initial damage caused by a heart attack. Furthermore, it may enable the design of future targeted therapies that interrupt the two inflammatory reactions to better protect a patient's heart muscle.
Previously, it was widely accepted that heart muscle responds in a stable and progressive way to a heart attack or blockage, with the response pattern starting right after the attack and lasting at least a week.
"Our study found that the inflammatory reaction of the heart post-heart attack is not stable or homogeneous," says senior study author Borja Ibáñez, MD, PhD, head of the Experimental Cardiology Group at CNIC and clinical cardiologist at the Hospital Clínico San Carlos in Spain. "In fact, we have identified that a new systematic and consistent two-wave inflammatory reaction occurs causing swelling and thickening of the heart muscle at two different times during a week's time."
The current research team first categorized this two-phase inflammatory response as an initial massive inflammatory reaction immediately after a myocardial infarction, accompanied by a massive increase in the myocardial tissue thickness that lasts a week. Subsequent observations, however, determined that a first wave of inflammation subsides a few hours after a heart attack, and then a second, separate wave of inflammation arises a week later.
"Our study shows the first evidence of the heart's dual inflammatory reaction after a myocardial infarction," says study author Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at Icahn School of Medicine at Mount Sinai and General Director of CNIC in Spain. "We now know the heart responds to a myocardial infarction in a different way than we once thought with the initial inflammatory reaction followed by a second reactive inflammatory wave. This new data may be truly paradigm-shifting for the future treatment of heart attack patients."
In the preclinical study, researchers performed comprehensive imaging using advanced 3 Tesla CMR technology to study the myocardium's inflammatory process, and later examined heart muscle tissue samples to assess its overall water content swelling.
This study was presented at the AHA Scientific Sessions 2014 as the Late-Breaking Clinical Trial, Abstract 24180: Myocardial Edema After Ischemia/Reperfusion is Not Stable and Follows a Bimodal Pattern: Advanced Imaging and Histological Tissue Characterization Study to Challenge a Classical Dogma.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.